We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$5.08M
2
SEZL
Sezzle
SEZL
+$3.99M
3
PSIX
Power Solutions International
PSIX
+$3.84M
4
QLYS icon
Qualys
QLYS
+$3.69M
5
PGNY icon
Progyny
PGNY
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIBK icon
126
First Interstate BancSystem
FIBK
$3.52B
$1.62M 0.37%
+42,000
New +$1.49M
GM icon
127
General Motors
GM
$74B
$1.62M 0.37%
+21,000
New +$1.65M
OLLI icon
128
Ollie's Bargain Outlet
OLLI
$4.35B
$1.61M 0.37%
21,000
– –
WAFD icon
129
WaFd
WAFD
$2.43B
$1.61M 0.37%
+42,000
New +$1.48M
TXG icon
130
10x Genomics
TXG
$9.47B
$1.61M 0.37%
42,000
-21,000
-33% -$550K
MD icon
131
Pediatrix Medical
MD
$2.12B
$1.6M 0.37%
63,000
– –
ACAD icon
132
Acadia Pharmaceuticals
ACAD
$4.75B
$1.59M 0.37%
63,000
-105,000
-63% -$2.31M
GNTX icon
133
Gentex
GNTX
$4.7B
$1.59M 0.37%
63,000
– –
GAP
134
The Gap Inc
GAP
$7.09B
$1.57M 0.36%
84,000
-21,000
-20% -$484K
NE icon
135
Noble Corp
NE
$7.08B
$1.57M 0.36%
42,000
– –
UHS icon
136
Universal Health Services
UHS
$10.7B
$1.56M 0.36%
10,500
– –
PVH icon
137
PVH
PVH
$3.31B
$1.56M 0.36%
21,000
– –
ST icon
138
Sensata Technologies
ST
$6.1B
$1.5M 0.35%
31,500
-10,500
-25% -$475K
LNC icon
139
Lincoln National
LNC
$8.13B
$1.48M 0.34%
+42,000
New +$1.51M
GOOG icon
140
Alphabet (Google) Class C
GOOG
$4.15T
$1.48M 0.34%
+4,200
New +$1.5M
SBAC icon
141
SBA Communications
SBAC
$19.1B
$1.48M 0.34%
8,400
– –
WEX icon
142
WEX
WEX
$6.72B
$1.48M 0.34%
+10,500
New +$1.56M
C icon
143
Citigroup
C
$223B
$1.47M 0.34%
10,500
– –
AMPX icon
144
Amprius Technologies
AMPX
$1.33B
$1.46M 0.34%
105,000
-42,000
-29% -$752K
PII icon
145
Polaris
PII
$3.15B
$1.44M 0.33%
+21,000
New +$1.35M
HAL icon
146
Halliburton
HAL
$28.8B
$1.43M 0.33%
+42,000
New +$1.64M
ANAB icon
147
AnaptysBio
ANAB
$1.61B
$1.42M 0.33%
21,000
– –
PRAX icon
148
Praxis Precision Medicines
PRAX
$8.63B
$1.41M 0.32%
4,200
– –
HP icon
149
Helmerich & Payne
HP
$4.16B
$1.38M 0.32%
+42,000
New +$1.57M
STOK icon
150
Stoke Therapeutics
STOK
$1.8B
$1.37M 0.32%
42,000
-42,000
-50% -$1.35M
4 5
6
7 8

Similar funds

NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $434M AUM 31.16% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $434M AUM 28.34% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $434M AUM 68.57% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.